Target Therapy in Hematological Malignances: New Monoclonal Antibodies

Apart from radio- and chemotherapy, monoclonal antibodies (MoAbs) represent a new, more selective tool in the treatment of hematological malignancies. MoAbs bind with the specific antigens of the tumors. This interaction is a basis for targeted therapies which exhibit few side effects and significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Podhorecka, Monika, Markowicz, Justyna, Szymczyk, Agnieszka, Pawlowski, Johannes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897146/
https://www.ncbi.nlm.nih.gov/pubmed/27433507
http://dx.doi.org/10.1155/2014/701493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4897146/
https://www.ncbi.nlm.nih.gov/pubmed/27433507
http://dx.doi.org/10.1155/2014/701493

Ejemplares similares